☆ 4.5 Article

Biomarkers of Inflammation Increase with Tau and Neurodegeneration but not with Amyloid-beta in a Heterogenous Clinical Cohort

JOURNAL OF ALZHEIMERS DISEASE (2022)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

The Gene Ontology resource: enriching a GOld mine

Seth Carbon et al.

Summary: The Gene Ontology Consortium has made advancements in the last two years, such as improving the GO-CAM annotation framework, increasing the number of annotations and annotated gene products, and reviewing older annotations for consistency.

NUCLEIC ACIDS RESEARCH (2021)

Add to Collection

Article Biochemistry & Molecular Biology

UniProt: the universal protein knowledgebase in 2021

Alex Bateman et al.

Summary: The UniProt Knowledgebase aims to provide users with a comprehensive, high-quality set of protein sequences annotated with functional information. Updates over the past two years have increased the number of sequences to approximately 190 million, with new methods to assess proteome completeness and quality. UniProtKB has responded to the COVID-19 pandemic by expertly curating relevant entries and making them rapidly available through a dedicated portal.

NUCLEIC ACIDS RESEARCH (2021)

Add to Collection

Article Multidisciplinary Sciences

Accelerated inflammatory aging in Alzheimer's disease and its relation to amyloid, tau, and cognition

Nicholas C. Cullen et al.

Summary: The study revealed that inflammatory proteins in both cerebrospinal fluid (CSF) and plasma are associated with cognitive impairment and AD pathology. The levels of inflammatory proteins varied across different stages of AD, with CSF inflammatory changes highly correlated with core AD biomarkers.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Clinical Neurology

Four subgroups based on tau levels in Alzheimer's disease observed in two independent cohorts

Flora H. Duits et al.

Summary: Using Gaussian mixture modeling, four subgroups were identified based on CSF t-tau and p-tau levels in two independent cohorts, with increasingly high tau subgroups associated with faster clinical decline and higher risk of progression to Alzheimer's disease.

ALZHEIMERS RESEARCH & THERAPY (2021)

Add to Collection

Article Neurosciences

Different Inflammatory Signatures in Alzheimer's Disease and Frontotemporal Dementia Cerebrospinal Fluid

Gustaf Bostrom et al.

Summary: The study revealed that levels of MMP-10 were elevated in AD, MCI/AD, and FTD patients, with additional proteins increased in MCI/AD. In contrast, FTD patients showed decreased levels of 36 proteins, while AD and MCI/AD patients did not show any decrease in protein levels. This suggests distinct patterns of neuroinflammatory processes in different neurodegenerative disorders.

JOURNAL OF ALZHEIMERS DISEASE (2021)

Add to Collection

Article Clinical Neurology

Changed signals of blood adenosine and cytokines are associated with parameters of sleep and/or cognition in the patients with chronic insomnia disorder

Chong-Yang Ren et al.

Summary: Patients with chronic insomnia disorder exhibit lower adenosine levels, higher ADA levels, and elevated levels of certain cytokines compared to healthy controls. Adenosine levels are negatively correlated with sleep quality index scores, while some cytokines are positively correlated with cognitive assessment scores.

SLEEP MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Adenosine deaminase modulates metabolic remodeling and orchestrates joint destruction in rheumatoid arthritis

Sai Krishna Srimadh Bhagavatham et al.

Summary: The study shows that different levels of adenosine deaminase (ADA), an arthritis-associated factor, can lead to varying cytokine levels and metabolic characteristics in rheumatoid arthritis (RA) patients. ADA may play a crucial role in the pathophysiology of RA joints, serving as a potential biomarker and therapeutic target for RA patients.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Geriatrics & Gerontology

Inflammatory Biomarkers Aid in Diagnosis of Dementia

Erik B. Erhardt et al.

Summary: This study diagnosed MX using biological criteria and MRI, measured multiple biomarkers with kits for proteases, angiogenic factors, and cytokines, and used machine learning to identify important biomarkers related to AD and VCID.

FRONTIERS IN AGING NEUROSCIENCE (2021)

Add to Collection

Article Geriatrics & Gerontology

Hyperactivation of monocytes and macrophages in MCI patients contributes to the progression of Alzheimer's disease

Usma Munawara et al.

Summary: The study found distinct phenotypic and functional changes in monocyte and macrophage populations as the disease progresses. Higher free radical production was observed in the monocytes of SMC patients, while the strongest activation of peripheral monocytes was seen in the MCI group. Monocytes exhibited increased chemotaxis, free radical production, and cytokine production in response to TLR2 and TLR4 stimulation, suggesting activation of the peripheral innate immune system during disease progression.

IMMUNITY & AGEING (2021)

Add to Collection

Article Cell Biology

Neuroinflammation and Alzheimer's Disease: A Machine Learning Approach to CSF Proteomics

Lorenzo Gaetani et al.

Summary: In this study, novel protein biomarkers reflecting neuroinflammation in Alzheimer's disease were identified using a high-throughput multiplex CSF analysis coupled with machine-learning. These biomarkers, including SIRT2, HGF, MMP-10, and CXCL5, showed high discriminatory performance in distinguishing AD patients from controls. The biological processes regulated by these proteins involve astrocyte and microglia activation, modulation of amyloid and tau misfolding, and dysfunction of the blood-brain barrier. Additional studies are needed to confirm these results and validate proximity extension assay as a technique for biomarker discovery in neurological diseases.

CELLS (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease

Huiqin Zhang et al.

Summary: Extracellular neuritic plaques and intracellular neurofibrillary tangles, composed of amyloid-beta and phosphorylated tau protein respectively, are hallmark proteins of Alzheimer's disease. The interactions between these proteins have been extensively studied, with A beta accelerating tau phosphorylation, tau mediating A beta toxicity, and potential synergistic effects on microglial cells and astrocytes. Understanding these interactions may lead to new interventions against Alzheimer's disease.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

Add to Collection

Article Clinical Neurology

Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays

Ashvini Keshavan et al.

Summary: The study assessed the concordance of CSF amyloid beta and tau measured on the Lumipulse platform with pre-symptomatic AD pathology on amyloid PET. Results showed that Lumipulse platform provides comparable sensitivity and specificity to established CSF immunoassays in identifying pre-symptomatic AD pathology.

ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2021)

Add to Collection

Review Cell Biology

The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer's disease

Alessandra Webers et al.

IMMUNOLOGY AND CELL BIOLOGY (2020)

Add to Collection

Article Clinical Neurology

Inflammation biomarker discovery in Parkinson's disease and atypical parkinsonisms

Anna Santaella et al.

BMC NEUROLOGY (2020)

Add to Collection

Review Medicine, General & Internal

Dementia prevention, intervention, and care: 2020 report of the Lancet Commission

Gill Livingston et al.

LANCET (2020)

Add to Collection

Article Medical Laboratory Technology

Adenosine Deaminase as a Useful Biomarker for Diagnosis and Monitoring of Inflammatory Bowel Disease

Mariyana Yordanova et al.

CLINICAL LABORATORY (2020)

Add to Collection

Article Clinical Neurology

The National Institute on Aging-Alzheimer's Association Framework on Alzheimer's disease: Application to clinical trials

Jeffrey Cummings

ALZHEIMERS & DEMENTIA (2019)

Add to Collection

Review Biochemical Research Methods

Proteomic signatures of neuroinflammation in Alzheimer's disease, multiple sclerosis and ischemic stroke

Camilla Thygesen et al.

EXPERT REVIEW OF PROTEOMICS (2019)

Add to Collection

Article Neurosciences

Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer's disease

Christopher D. Whelan et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)

Add to Collection

Article Geriatrics & Gerontology

Proinflammatory and anti-inflammatory cytokines in the CSF of patients with Alzheimer's disease and their correlation with cognitive decline

Ricardo Taipa et al.

NEUROBIOLOGY OF AGING (2019)

Add to Collection

Article Pharmacology & Pharmacy

Serum adenosine deaminase activity and coronary artery disease: a retrospective case-control study based on 9929 participants

Chao Xuan et al.

THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2019)

Add to Collection

Article Clinical Neurology

Purine-related metabolites and their converting enzymes are altered in frontal, parietal and temporal cortex at early stages of Alzheimer's disease pathology

Patricia Alonso-Andres et al.

BRAIN PATHOLOGY (2018)

Add to Collection

Article Clinical Neurology

Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study

Clifford R. Jack et al.

LANCET NEUROLOGY (2017)

Add to Collection

Article Multidisciplinary Sciences

A subcellular map of the human proteome

Peter J. Thul et al.

SCIENCE (2017)

Add to Collection

Article Clinical Neurology

Unbiased estimates of cerebrospinal fluid β-amyloid 1-42 cutoffs in a large memory clinic population

Daniela Bertens et al.

ALZHEIMERS RESEARCH & THERAPY (2017)

Add to Collection

Article Cardiac & Cardiovascular Systems

New thrombolytic strategy providing neuroprotection in experimental ischemic stroke: MMP10 alone or in combination with tissue-type plasminogen activator

Carmen Roncal et al.

CARDIOVASCULAR RESEARCH (2017)

Add to Collection

Review Clinical Neurology

Tau: From research to clinical development

David M. Holtzman et al.

ALZHEIMERS & DEMENTIA (2016)

Add to Collection

Article Immunology

Stromelysin-2 (MMP10) Moderates Inflammation by Controlling Macrophage Activation

Ryan S. McMahan et al.

JOURNAL OF IMMUNOLOGY (2016)

Add to Collection

Review Clinical Neurology

Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease

Kaj Blennow et al.

ALZHEIMERS & DEMENTIA (2015)

Add to Collection

Review Clinical Neurology

Neuroinflammation in Alzheimer's disease

Michael T. Heneka et al.

LANCET NEUROLOGY (2015)

Add to Collection

Article Clinical Neurology

A diagnostic scale for Alzheimer's disease based on cerebrospinal fluid biomarker profiles

Sylvain Lehmann et al.

ALZHEIMERS RESEARCH & THERAPY (2014)

Add to Collection

Review Behavioral Sciences

Inflammatory process in Alzheimer's Disease

Marco A. Meraz-Rios et al.

FRONTIERS IN INTEGRATIVE NEUROSCIENCE (2013)

Add to Collection

Article Neurosciences

Cerebrospinal Fluid Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Combination with Subcortical and Cortical Biomarkers in Vascular Dementia and Alzheimer's Disease

Maria Bjerke et al.

JOURNAL OF ALZHEIMERS DISEASE (2011)

Add to Collection

Review Biochemistry & Molecular Biology

Amyloid β-Protein Toxicity and the Pathogenesis of Alzheimer Disease

Bruce A. Yankner et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2009)

Add to Collection

Article Multidisciplinary Sciences

A functional genetic variation of adenosine deaminase affects the duration and intensity of deep sleep in humans

JV Rétey et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Add to Collection

Article Biochemistry & Molecular Biology

Dominant localization of adenosine deaminase in leptomeninges and involvement of the enzyme in sleep

T Okada et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.